380 related articles for article (PubMed ID: 11931574)
21. Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study.
Brazier L; Tiret L; Luc G; Arveiler D; Ruidavets JB; Evans A; Chapman J; Cambien F; Thillet J
Atherosclerosis; 1999 Jun; 144(2):323-33. PubMed ID: 10407493
[TBL] [Abstract][Full Text] [Related]
22. The relationship between plasma apolipoprotein A-IV levels and coronary heart disease.
Manpuya MW; Guo J; Zhao Y
Chin Med J (Engl); 2001 Mar; 114(3):275-9. PubMed ID: 11780313
[TBL] [Abstract][Full Text] [Related]
23. The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease.
Kalina A ; Császár A; Füst G; Nagy B; Szalai C; Karádi I; Duba J; Prohászka Z; Horváth L; Dieplinger H
Clin Chim Acta; 2001 Jul; 309(1):45-51. PubMed ID: 11408005
[TBL] [Abstract][Full Text] [Related]
24. Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene.
Ribeiro S; Faria Mdo S; Silva G; Nascimento H; Rocha-Pereira P; Miranda V; Vieira E; Santos R; Mendonça D; Quintanilha A; Costa E; Belo L; Santos-Silva A
Hemodial Int; 2012 Oct; 16(4):481-90. PubMed ID: 22515595
[TBL] [Abstract][Full Text] [Related]
25. Association between triglyceride-rich lipoprotein remnant receptor polymorphisms and lipid traits.
Song J; Hong SH; Min W; Kim JQ
Clin Biochem; 2000 Aug; 33(6):441-7. PubMed ID: 11074235
[TBL] [Abstract][Full Text] [Related]
26. Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T(+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians.
Valenti K; Aveynier E; Leauté S; Laporte F; Hadjian AJ
Atherosclerosis; 1999 Nov; 147(1):17-24. PubMed ID: 10525120
[TBL] [Abstract][Full Text] [Related]
27. Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma.
Mooser V; Mancini FP; Bopp S; Pethö-Schramm A; Guerra R; Boerwinkle E; Müller HJ; Hobbs HH
Hum Mol Genet; 1995 Feb; 4(2):173-81. PubMed ID: 7757064
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein(a) gene polymorphisms (TTTTA)n and G/A-914 affect Lp(a) levels in ischemic heart disease patients from Serbia.
Dincić D; Zivković M; Stanković A; Djurić T; Vujanić S; Gligić B; Alavantić D
Wien Klin Wochenschr; 2005 Jun; 117(11-12):406-11. PubMed ID: 16053196
[TBL] [Abstract][Full Text] [Related]
29. Genetic effect of two APOA repeat polymorphisms (kringle 4 and pentanucleotide repeats) on plasma Lp(a) levels in American Samoans.
DePrince K; McGarvey ST; McAllister AE; Bausserman L; Aston CE; Ferrell RE; Kamboh MI
Hum Biol; 2001 Feb; 73(1):91-104. PubMed ID: 11332648
[TBL] [Abstract][Full Text] [Related]
30. Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels.
Cohen JC; Chiesa G; Hobbs HH
J Clin Invest; 1993 Apr; 91(4):1630-6. PubMed ID: 8473506
[TBL] [Abstract][Full Text] [Related]
31. LPA gene: interaction between the apolipoprotein(a) size ('kringle IV' repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein level.
Røsby O; Berg K
J Intern Med; 2000 Jan; 247(1):139-52. PubMed ID: 10672142
[TBL] [Abstract][Full Text] [Related]
32. Pentanucleotide TTTTA repeat polymorphism of apolipoprotein(a) gene and plasma lipoprotein(a) are associated with ischemic and hemorrhagic stroke in Chinese: a multicenter case-control study in China.
Sun L; Li Z; Zhang H; Ma A; Liao Y; Wang D; Zhao B; Zhu Z; Zhao J; Zhang Z; Wang W; Hui R
Stroke; 2003 Jul; 34(7):1617-22. PubMed ID: 12791946
[TBL] [Abstract][Full Text] [Related]
33. The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration.
Kraft HG; Köchl S; Menzel HJ; Sandholzer C; Utermann G
Hum Genet; 1992 Nov; 90(3):220-30. PubMed ID: 1336760
[TBL] [Abstract][Full Text] [Related]
34. Effects of apolipoprotein A gene polymorphisms on lipoprotein (a) concentrations in Japanese.
Park HY; Nabika T; Notsu Y; Kobayashi S; Masuda J
Clin Exp Pharmacol Physiol; 1999 Apr; 26(4):304-8. PubMed ID: 10225140
[TBL] [Abstract][Full Text] [Related]
35. Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random.
Kraft HG; Lingenhel A; Pang RW; Delport R; Trommsdorff M; Vermaak H; Janus ED; Utermann G
Eur J Hum Genet; 1996; 4(2):74-87. PubMed ID: 8744025
[TBL] [Abstract][Full Text] [Related]
36. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).
Saku K; Zhang B; Liu R; Shirai K; Arakawa K
Jpn Circ J; 1999 Sep; 63(9):659-65. PubMed ID: 10496479
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein A polymorphisms and plasma lipoprotein(a) concentrations in non-Hispanic Whites and Hispanics.
Chiu L; Hamman RF; Kamboh MI
Hum Biol; 2000 Oct; 72(5):821-35. PubMed ID: 11126727
[TBL] [Abstract][Full Text] [Related]
38. Pentanucleotide repeat and size polymorphisms in the apolipoprotein(a) gene are associated with the lipoprotein(a) concentration in chronic hemodialysis patients.
Tanaka M; Yanagi H; Ando R; Kurihara S; Hirano C; Kobayashi K; Kikuchi S; Hamaguchi H; Tsuchiya S; Tomura S
Nephron; 1999; 81(4):414-20. PubMed ID: 10095177
[TBL] [Abstract][Full Text] [Related]
39. Single effects of apolipoprotein B, (a), and E polymorphisms and interaction between plasminogen activator inhibitor-1 and apolipoprotein(a) genotypes and the risk of coronary artery disease in Czech male caucasians.
Benes P; Muzík J; Benedík J; Frélich M; Elbl L; Vasků A; Znojil V; Vácha J
Mol Genet Metab; 2000 Feb; 69(2):137-43. PubMed ID: 10720441
[TBL] [Abstract][Full Text] [Related]
40. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension.
Sechi LA; Kronenberg F; De Carli S; Falleti E; Zingaro L; Catena C; Utermann G; Bartoli E
JAMA; 1997 Jun; 277(21):1689-95. PubMed ID: 9169895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
